Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
2,315.00
Ask:
2,320.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

5 Feb 2026 07:00

RNS Number : 7717R
RIT Capital Partners PLC
05 February 2026
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

5 February 2026

December 2025 Preliminary Unaudited Net Asset Value

RIT Capital Partners plc ("RIT") announces that its preliminary unaudited diluted NAV as at 31 December 2025 (with debt at fair value) was 2,921p per £1 ordinary share (30 November 2025: 2,899p). This represents a +0.8% total return for the month, outperforming the ACWI (50% £) at +0.1%.

The preliminary 31 December 2025 NAV is equivalent to a NAV per share total return for the year of +13.5%, with double-digit returns across all three investment pillars (Quoted Equities, Private Investments and Uncorrelated Strategies). Our annualised NAV per share total return since inception is +10.6%, underscoring our commitment to delivering healthy, long-term returns for our shareholders.

As is customary at this point in our year-end process, the preliminary NAV and associated performance numbers for 2025 are estimates, and subject to potential adjustment and audit. Full details will be included in the 2025 Annual Report and Accounts, which is expected to be published by early March 2026.

December 2025 Performance Highlights

RIT delivered resilient performance, demonstrating the benefits of our diversified global portfolio. Performance was led by Private Investments and Uncorrelated Strategies which contributed positively to NAV. Quoted Equities detracted modestly during the month, while the continued strengthening of sterling against the US dollar resulted in a negative translation effect on our global portfolio.

-

In Quoted Equities, weakness in technology and biotech stocks was partially offset by strong performance in our quality theme and emerging markets related holdings.

-

Private Investments delivered positive returns, helped by an uplift in December valuations of our direct holdings. As of 31 December 2025, more than 99% of our private funds were held at 30 September 2025 reported valuations and all private direct holdings were valued as at 31 December 2025, in line with our valuation policy.

-

Uncorrelated Strategies, which acts as a steady diversifier of returns, contributed positively to our NAV, supported by gold and credit.

-

We continued our share buyback programme, buying back £13.4m or approximately 593,000 shares in December, adding an estimated +9bps accretion to NAV. As at 31 December 2025, the total share capital repurchased through buybacks since the start of the year amounted to 3% at a total value of £89.0m.

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Deutsche Numis (Joint broker):

Nathan Brown, Vicki Paine

T: 020 7260 1000

 

JP Morgan Cazenove Limited (Joint broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group (Media enquiries):

Nick Cosgrove, Peter Hesse

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZLFBQLLLBBX
Date   Source Headline
4th Feb 20259:18 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20252:23 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20255:13 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSShare Buyback Management
2nd Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSNet Asset Value(s)
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202411:57 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSNet Asset Value(s)
18th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 202411:20 amRNSComposition of Conflicts Committee
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 202412:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.